Experimental drug aims to save lives after heart stops
NCT ID NCT07468292
Summary
This study tests whether a drug called GC7 can reduce organ damage in people who survived cardiac arrest. Researchers want to see if GC7 lowers harmful stress in the blood that often occurs after the heart is restarted. The study will measure oxidative stress, blood acidity, and inflammation in 20 patients who recently experienced cardiac arrest.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC ARREST (CA) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Nice - Hôpital PASTEUR 2
Nice, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.